Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
骨髓核型在遗传性骨髓衰竭综合征中的意义
基本信息
- 批准号:8552778
- 负责人:
- 金额:$ 10.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAplastic AnemiaBiologicalBone MarrowChromosome abnormalityClinicalCytogenetic AnalysisCytogeneticsDataDatabasesDetectionDiamondDiamond-Blackfan anemiaDiseaseDyskeratosis CongenitaDysmyelopoietic SyndromesFanconi&aposs AnemiaFluorescent in Situ HybridizationG-BandingHereditary DiseaseIncidenceInheritedKaryotypeLaboratoriesMarrowMethodsMolecular CytogeneticsMorphologyPancytopeniaPatientsPreparationPublishingRiskRunningSpectral KaryotypingSyndromeTechnologyTestingTimeWaxesadverse outcomeclinically significantcohortcomparative genomic hybridizationcytopeniaprospectiveresponse
项目摘要
The inherited bone marrow failure syndromes (IBMFS) are a heterogeneous group of rare genetic disorders with distinctive phenotypic and laboratory abnormalities. Patients with IBMFS, including Fanconi Anemia (FA), Diamond-Blackfan Anemia (DBA), Shwachman-Diamond Syndrome (SDS), and Dyskeratosis Congenita (DC), have an increased risk of developing aplastic anemia (AA), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). To determine the incidence, types, and possible clinical significance of abnormal bone marrow karyotypes among patients with IBMFS, we are conducting prospective, serial, routine and molecular cytogenetic analyses of marrow. We hypothesize that abnormal marrow karyotypes, without other evidence of MDS (significant cytopenias or morphologic dyspoiesis), may not predict an adverse outcome. Analyses have included centrally-reviewed marrow morphology, G-banded karyotype analysis, fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH) and spectral karyotyping (SKY). Patients have been followed for up to nine years. Clonal chromosome abnormalities have been detected in nine of 19 (47 percent) patients with FA, none of 26 (0 percent) patients with DBA, three of five (60 percent) patients with SDS, and three of 27 (11 percent) patients with DC. G-banding is the best method for detecting abnormal clones, and FISH provides additional information; CGH is the least sensitive method. Approximately half of the clonal abnormalities documented among our patients with IBMFS are different from those commonly found in patients with sporadic MDS or AML. Abnormal clones have been found in IBMFS patients who are clinically stable and do not have morphologic MDS. Furthermore, some of these clones have waxed and waned over time. These data suggest the clinical, and possibly biological, significance of cytogenetic changes in IBMFS may be different from other patients with de novo bone marrow failure or MDS. We are currently completing and verifying our clinical, cytogenetic, and marrow morphology databases in preparation for running cross-sectional and longitudinal analyses and publishing the findings in this unique cohort of patients.
遗传性的骨髓衰竭综合征(IBMF)是一群具有独特表型和实验室异常的稀有遗传疾病的异质群。 Patients with IBMFS, including Fanconi Anemia (FA), Diamond-Blackfan Anemia (DBA), Shwachman-Diamond Syndrome (SDS), and Dyskeratosis Congenita (DC), have an increased risk of developing aplastic anemia (AA), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). 为了确定IBMF患者中异常骨髓核型的发生率,类型和可能的临床意义,我们正在进行骨髓的前瞻性,连续性,常规,常规和分子细胞遗传学分析。 我们假设异常的骨髓核型,没有其他MDS的证据(明显的细胞质或形态呼吸障碍)可能无法预测不良结果。分析包括中央回顾的骨髓形态,G带核型分析,荧光原位杂交(FISH),比较基因组杂交(CGH)和光谱核分型(SKY)。 患者已遵循多达9年。 在FA患者中有9例(47%)患者中有9名(47%)患者中有9例(47%)患者,患有DBA的患者中有9名(60%(60%)患有SDS的患者中有3例(47%)患者中有9例(47%)患者,有27例(11%)患者中有3例(11%(11%)患者中,有26名(0%)患者中,已检测到克隆染色体异常。 G带是检测异常克隆的最佳方法,Fish提供了其他信息。 CGH是最不灵敏的方法。在我们的IBMF患者中,约有一半的克隆异常与偶发的MDS或AML患者常见的患者不同。 在临床上稳定且没有形态MD的IBMFS患者中发现了异常克隆。 此外,这些克隆中的一些随着时间的流逝而逐渐减弱。 这些数据表明,IBMF中细胞遗传学变化的临床或可能是生物学的意义可能与其他从头骨髓衰竭或MDS的患者不同。我们目前正在完成并验证我们的临床,细胞遗传学和骨髓形态数据库,以准备进行横截面和纵向分析,并在这一独特的患者队列中发布发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
diane c arthur其他文献
diane c arthur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('diane c arthur', 18)}}的其他基金
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
骨髓核型在遗传性骨髓衰竭综合征中的意义
- 批准号:
7733156 - 财政年份:
- 资助金额:
$ 10.3万 - 项目类别:
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
B 细胞慢性淋巴细胞白血病 (B-CLL) 的细胞遗传学研究
- 批准号:
7969821 - 财政年份:
- 资助金额:
$ 10.3万 - 项目类别:
Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fa
遗传性骨髓 Fa 患者骨髓核型的意义
- 批准号:
7592858 - 财政年份:
- 资助金额:
$ 10.3万 - 项目类别:
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
B 细胞慢性淋巴细胞白血病 (B-CLL) 的细胞遗传学研究
- 批准号:
8554041 - 财政年份:
- 资助金额:
$ 10.3万 - 项目类别:
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
B 细胞慢性淋巴细胞白血病 (B-CLL) 的细胞遗传学研究
- 批准号:
8350074 - 财政年份:
- 资助金额:
$ 10.3万 - 项目类别:
相似国自然基金
红系造血岛巨噬细胞TLR8信号激活在再生障碍性贫血中机制研究
- 批准号:82370144
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
骨髓树突状细胞TLR1/2/8-MyD88通路在再生障碍性贫血发生发展中的作用
- 批准号:82370142
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
三氧化二砷通过抑制骨髓巨噬细胞糖代谢重编程治疗再生障碍性贫血的机制研究
- 批准号:82370143
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
再生障碍性贫血的免疫异常机制研究
- 批准号:82370119
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
BeAn 58058病毒影响cofilin 1功能介导重型再生障碍性贫血患者髓样树突状细胞激活及其机制的研究
- 批准号:82300239
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Multi-faceted Roles of an Atypical Kinase RIOK2 in Erythropoiesis and Myelodyplastic Syndromes
非典型激酶 RIOK2 在红细胞生成和骨髓增生异常综合征中的多方面作用
- 批准号:
10046930 - 财政年份:2020
- 资助金额:
$ 10.3万 - 项目类别:
DCEG- Molecular Assays for epidemiology studies
DCEG-流行病学研究的分子测定
- 批准号:
10199837 - 财政年份:2019
- 资助金额:
$ 10.3万 - 项目类别:
Early Clonal Evolution in Acquired Aplastic Anemia
获得性再生障碍性贫血的早期克隆进化
- 批准号:
9276506 - 财政年份:2016
- 资助金额:
$ 10.3万 - 项目类别: